Our new report is making the media rounds…
From ways to eavesdrop on brains and learn what advertisements excite consumers, to devices that alleviate depression, the number of U.S. patents awarded for “neurotechnology” has soared since 2010, according to an analysis released on Wednesday.
“Neurotech has gone well beyond medicine, with non-medical corporations, often under the radar, developing neurotechnologies to enhance work and life,” Alvaro Fernandez said.
One interesting patent example the SharpBrains cited (without revealing the patent holder’s identity) measures a subject’s threshold concentration to determine the appropriate time to allow a notification interruption.
CCTV-America: Virtual reality startups take users to another dimension
Market research firm SharpBrains says neurotech is extending into more industries than ever, with five times the number of non-invasive neurotech patents being granted today compared to a decade ago.
“Nielsen has made a substantial investment in neurotechnology over the past several years, which is reflected in the size of our patent portfolio,” said Joe Wilke, President, Nielsen Neuro. “It’s gratifying to be recognized by the SharpBrains study as the leader in this exciting new area.”